Companies: 10,795·Total market cap: $144.5T
Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc.

VNDANASDAQHealthcare● Active
$6.02
$-0.01(-0.23%)
Market Cap$361775541
P/E Ratio
52W High$9.94
52W Low$4.14
Overview

Vanda Pharmaceuticals Inc. (VNDA) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · VNDA · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-4.05vnda eps ttm · vnda earnings per shareEarnings history
PE Ratio (TTM)vnda pe ratio ttm · vnda price to earningsPE Ratio deep dive
Revenue (TTM)$217.8Mvnda revenue ttm · vnda annual revenueFull revenue history
Dividend YieldNo Dividenddoes vnda pay dividends · vnda dividend yieldDividend history
Shares Outstanding58.9Mvnda shares outstanding · vnda floatShares outstanding history
Next EarningsJul 30, 2026Est.vnda earnings date · vnda next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$216.1M▲ +8.72% YoY
202320242025
vanda pharmaceuticals inc. revenue · vnda revenue 2025
FY 2025Net Income-$220.5M▼ 1066.53% YoY
202320242025
vanda pharmaceuticals inc. net income · vnda profit 2025
FY 2025EPS$-3.74▼ 1068.75% YoY
202320242025
vnda eps · vanda pharmaceuticals inc. earnings per share 2025
TTM:Revenue: $217.8MNet Income: -$239.5MEPS: $-4.05View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy19 analystsis vnda a buy · vnda analyst rating
Strong Buy
0
Buy
13
Hold
5
Sell
1
Strong Sell
0
12-Month Price Target
$7.50Low
$6.02Current
$14.25Avg Target136.87% upside
$21.00High
vnda price target · vnda 12 month forecast

Total: 19 · Buy rate: 68.4%

The VNDA analyst consensus is Buy, based on ratings from 19 Wall Street analysts over the past 3 months. The average 12-month price target is $14.25, representing +136.87% upside from the current price of $6.02.

Stock Performance

Full History
1D-1.08%
1W-3.17%
1M-5.02%
3M-24.40%
YTD-32.37%
1Y+29.96%
5Y-68.20%

About Vanda Pharmaceuticals Inc.

CEOMihael H. Polymeropoulos
IPO DateApr 12, 2006
Employees368
CountryUS

Vanda Pharmaceuticals Inc. a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETL…

what is vanda pharmaceuticals inc. · vnda stock overview · vanda pharmaceuticals inc. company profile · who is vanda pharmaceuticals inc. ceo · vnda NASDAQ · vanda pharmaceuticals inc. headquarters · vanda pharmaceuticals inc. business segments

About Stock Overview & Key Data

Vanda Pharmaceuticals Inc. (VNDA) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Apr 12, 2006. As of the latest trading session, VNDA stock price is $6.02, with a market capitalization of $358.7M. The stock has returned +29.96% over the past 12 months and -32.37% year-to-date.

According to 19 Wall Street analysts, the consensus rating for Vanda Pharmaceuticals Inc. stock is Buy, with an average 12-month price target of $14.25. In fiscal year 2025, Vanda Pharmaceuticals Inc. reported revenue of $216.1M and net income of -$220.5M. For detailed data — including Vanda Pharmaceuticals Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Vanda Pharmaceuticals Inc. (VNDA) stock price is $6.02. The stock is traded on NASDAQ under the ticker symbol VNDA. The 52-week range is $4.14 – $9.94.

VNDA stock priceVNDA quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice